01 What is Epitalon?
In plain English.
Epitalon is a lab-made peptide just four amino acids long, alanine, glutamic acid, aspartic acid and glycine, abbreviated AEDG. It was designed in the 1980s by Prof. Vladimir Khavinson and colleagues at the Saint Petersburg Institute of Bioregulation and Gerontology as a synthetic stand-in for a fragment they had isolated from epithalamin, a crude bovine pineal-gland extract. The two names get used interchangeably online, but they are different things: epithalamin is an animal-tissue extract; Epitalon is one short synthetic peptide drawn from it.
Epitalon sits at the centre of a body of work, life-extension in mice, telomerase activation in human cell cultures, reduced mortality in elderly cohorts, produced over 25 years almost entirely by Khavinson's group and collaborators. Mainstream Western gerontology has not replicated it. That is the single most important fact about this peptide, and most online write-ups omit it.
02 How it works
The simple version, then the science.
The proposed mechanism is that Epitalon "wakes up" the pineal gland, restores age-related decline in melatonin output, and switches on telomerase, the enzyme that maintains the protective caps on the ends of chromosomes. In theory, longer telomeres mean cells that can divide more times before senescence, which the original investigators framed as a route to slower biological ageing.
Go deeper · the proposed mechanism
Cell-culture work from the originating group reported that Epitalon induced telomerase activity and elongated telomeres in human fetal and adult fibroblasts (Khavinson et al., Bull Exp Biol Med, 2003). Subsequent papers from the same lab and its collaborators described effects on pineal melatonin secretion, interleukin-2 levels, and various enzyme activities. A 2025 Polish review notes that, despite 25 years of literature, the actual molecular mechanism remains unclear and the physico-chemical characterisation of the peptide is "very limited." None of the proposed mechanisms, telomerase activation, pineal regulation, antioxidant effects, has been confirmed by an independent Western laboratory.
03 What it's used for
Each use graded by how strong the evidence actually is.
- PreclinicalLifespan extension (rodents)Reported in mouse and rat studies from the originating group. Not independently replicated.
- PreclinicalTelomerase activation in cell cultureReported in human fibroblast cultures by Khavinson et al. (2003). The single most-cited mechanistic claim, and the one with the weakest independent confirmation.
- LimitedReduced mortality in elderly cohorts (claimed)A series of long-running clinical studies from the St. Petersburg / Kyiv groups report 28%–60% mortality reductions over 6–15 years. The trials were not blinded to modern standards, were conducted by the developers, and have not been replicated.
- AnecdotalAnti-ageing, skin and sleep (marketed)Widely sold by online vendors and a handful of "anti-ageing" clinics. No controlled human data supporting these specific uses.
04 What the evidence says
The Epitalon literature is unusual. There is a lot of it, over a hundred papers across two decades, but almost all of it traces to Prof. Vladimir Khavinson, his St. Petersburg institute, and a small circle of collaborators in Russia and Ukraine. Western mainstream gerontology has not picked up the work: there are no Phase 2/3 trials registered with the FDA or EMA, no replications of the headline telomerase or lifespan results from independent labs, and no inclusion in mainstream anti-ageing review articles. The published clinical studies report striking outcomes (mortality cut by a third or more in elderly cohorts) using methods, unblinded designs, developer-run trials, peptide-bioregulator scoring frameworks devised by the same group, that would not pass modern regulatory review. A 2025 review in the International Journal of Molecular Sciences, while broadly favourable, concedes that the molecular mechanism "remains unclear" after 25 years. Independent replication is the currency of modern science; its 25-year absence here is itself strong evidence. Honest position: an interesting hypothesis with a body of supportive but methodologically thin in-house data, and no confirmed human benefit.
05 Dosing & administration
Reported in the literature, information not advice.
There is no approved human protocol for Epitalon, so no safe or effective dose has been established by a regulator. Vendor and forum sources describe milligram-range subcutaneous injections in short "cycles," typically based on the dosing schedules used in the original Russian clinical studies, but those studies themselves are not gold-standard trials, and the peptide sold online is not the same regulated material. A qualified clinician should be consulted before considering any peptide.
06 Side effects & safety
Long-term safety in humans is unknown. The published trials from the originating group report few adverse events, but those trials were small, unblinded, and run by the peptide's developers, so the safety signal is weak. A specific theoretical concern is telomerase activation: telomerase is upregulated in the majority of human cancers, and any agent that genuinely activates it carries a theoretical risk of accelerating the growth of existing tumours. This has not been demonstrated clinically but is a reasonable basis for caution in anyone with a cancer history. Products sold online as "Epitalon" are unregulated research chemicals, purity, sterility and dose-by-dose consistency are not guaranteed. People who are pregnant, breastfeeding, immunocompromised, have a cancer history, or take other medicines should be especially cautious.
07 Where to buy (research use only)
Vetted on quality and transparency, not an endorsement to use.
08 Legal & regulatory status
- UKNot licensed as a medicine. Sold only as a "research chemical", not for human use. Some private "anti-ageing" clinics offer it off-label, note that "off-label" implies an approved medicine, which Epitalon is not.
- USNot FDA-approved. Not on the FDA's list of bulk substances permitted for compounding. Sold as a research chemical only.
- EU / AUS / CANNo approved human medicine containing Epitalon. Sale for human use is unlawful in most jurisdictions; "research use only" framing is standard. In Russia, the parent extract epithalamin has historically been sold under bioregulator-peptide regulations that have no equivalent in Western pharmacovigilance.
- Sport (WADA)
09 Clinical studies & research
Primary sources. Read the science yourself.